Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz in Advanced Pancreatic Adenocarcinoma
NCT00964171Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of efavirenz in pancreatic adenocarcinoma (PDAC), sponsored by Institut Bergonié. Started Aug 2008; status: completed.
02
Drugs
efavirenz
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00964171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964171.